Frequently Asked Questions
A registry is an observational study that collects data to learn from real patients’ experiences with treatments and health conditions. This data helps researchers and physicians understand how treatments work in everyday life. The CELLEBRATE Registry will collect data to learn more about the long-term safety and effectiveness of iltamiocel (AMDC-USR injection).
Participation in the CELLEBRATE Registry is limited to participants who were enrolled in the CELLEBRATE Study and who:
-
Completed their participation in the past 15 months.
-
Received at least 1 dose of iltamiocel (AMDC-USR injection).
-
Have received a previous surgery for treatment of stress urinary incontinence (SUI).
-
Your participation in the CELLEBRATE Registry will last for 5 years.
After consenting to participate in the registry and completing a baseline visit, you will engage in brief annual electronic questionnaires and phone check-ins with our research team for five years.
Your baseline visit may be conducted remotely (phone call) or in person. All annual visits will be conducted by phone.
Compensation will be provided to participants in the registry. Details related to compensation will be included in the informed consent documentation you will review prior to consenting to the study.
You will receive access to your questionnaire via email. Each questionnaire will take approximately 30 minutes to complete.
Complete this form to let our study team know you would like to participate or learn more.